FDA Notices, Guidances Should Reflect St. John's Wort Interaction - CHPA

Center for Drug Evaluation & Research health advisories and guidances should be amended to communicate potential interactions of St. John's wort with certain types of Rx drugs, CHPA tells FDA.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet